본문

  1. Home
9 Results:AA:ODE A PP:ELSEVIER INC 0.421 sec.
RSS 
다국어입력
 상세검색
 신착검색
선택출력 선택엑셀내보내기
1
The excess mortality due to periprosthetic femur fracture. A study from the Swedish national hip arthroplasty register
The excess mortality due to periprosthetic femur fracture. A study from the Swedish national hip arthroplasty register
Lindahl, H., | Elsevier Inc | 2007 ,
2
Intervention thresholds for osteoporosis in the UK
Intervention thresholds for osteoporosis in the UK
Kanis, J. A., | Elsevier Inc | 2005 ,
3
The excess mortality due to periprosthetic femur fracture. A study from the Swedish national hip arthroplasty register
The excess mortality due to periprosthetic femur fracture. A study from the Swedish national hip arthroplasty register
Lindahl, H., | Elsevier Inc | 2008 ,
4
Delayed bone age due to a dual effect of FGFR3 mutation in Achondroplasia
Delayed bone age due to a dual effect of FGFR3 mutation in Achondroplasia
Pannier, S., | Elsevier Inc | 2010 ,
5
FRAX and its applications in health economics-Cost-effectiveness and intervention thresholds using bazedoxifene in a Swedish setting as an example
FRAX and its applications in health economics-Cost-effectiveness and intervention thresholds using bazedoxifene in a Swedish setting as an example
Strom, O., | Elsevier Inc | 2010 ,
6
A meta-analysis of the efficacy of raloxifene on all clinical and vertebral fractures and its dependency on FRAX(R)
A meta-analysis of the efficacy of raloxifene on all clinical and vertebral fractures and its dependency on FRAX(R)
Kanis, J. A., | Elsevier Inc | 2010 ,
7
Sex-specific compromised bone healing in female rats might be associated with a decrease in mesenchymal stem cell quantity
Sex-specific compromised bone healing in female rats might be associated with a decrease in mesenchymal stem cell quantity
Strube, P., | Elsevier Inc | 2009 ,
8
FRAX® and its applications to clinical practice
FRAX® and its applications to clinical practice
Kanis, J. A., | Elsevier Inc | 2009 ,
9
Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX®
Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX®
Kanis, J. A., | Elsevier Inc | 2009 ,
처음1마지막